Cisplatin-tethered gold nanoparticles that exhibit enhanced reproducibility, drug loading, and stability: a step closer to pharmaceutical approval? J Domínguez-Robles, C Mancinelli, E Mancuso, I...

Professor Dimitrios A. Lamprou (Ph.D. MBA) is the Chair of Biofabrication and Advanced Manufacturing, Director of Internationalisation (DoI), and Director at MSc Industrial Pharmaceutics at School of Pharmacy (ranked 35 in the world) at Queen's University Belfast.

2025年2月4日 · Professor Dimitrios Lamprou (Ph.D. MBA) is a subject matter expert in emerging (bio)pharmaceutical technologies for drug delivery systems and medical implants.

Professor Dimitrios Lamprou School of Pharmacy The Lamprou Research Lab, is focusing on Emerging Technologies (e.g., 3D Printing / 4D Printing & Bioprinting, Electrospinning, Microfluidics & Lab-on-a-chip, and BioMEMS) for Drug Delivery Systems and …

Dimitrios, has been recognized as world leader in 3D Printing & Microfluidics. PubMed-based algorithms placed him in the top 0.01% of scholars in the world writing about Printing and in the top 0.07% of scholars in the world writing about microfluidics, over the past 10 years.

Dimitrios A Lamprou Electrospinning is an innovative technique that allows production of nanofibers and microfibers by applying a high voltage to polymer solutions of melts.

‪Principal Investigator (PI) | Professor at Queen's University Belfast‬ - ‪‪Cited by 5,943‬‬ - ‪3D Printing‬ - ‪Drug Delivery‬ - ‪Emerging Technologies‬ - ‪Microfluidics‬ - ‪Sustainability‬

Professor Lamprou (Ph.D. MBA), Chair of Biofabrication & Advanced Manufacturing at Queen's University Belfast, has been recognised as world leader in 3D Printing with PubMed-based algorithms placed him in the top 0.088% of scholars in …

Dimitrios Lamprou Dimitrios joined the School of Pharmacy in May 2018 as Reader in Pharmaceutical Engineering. He is originally from Greece, and has been trained in multi-disciplinary areas and in first class laboratories in Greece, UK and USA.